Literature DB >> 174852

The inheritance of hyperlipoproteinaemia with xanthomatosis. A study of 132 kindreds.

A Heiberg, K Berg.   

Abstract

In a study of xanthomatosis kindreds in the county of Ostfold, Norway, 95 % of the living first degree relatives of the probands were investigated. Hyperlipoproteinaemia (lipid values above the 95th percentile) was present in 40.8 % of 554 first degree relatives of probands with xanthomatosis. The distribution curve was bimodal for cholesterol and LDL cholesterol concentrations, but not for triglyceride concentration within the different categories of families. The IIA lipoprotein pattern was the most frequent lipoprotein abnormality, in probands as well as in affected first degree relatives. However, IIB and IV lipoprotein patterns were also found in affected family members, irrespective of the pattern in the probands. About 93% of the xanthomatosis subjects had a lipoprotein disorder segregating as an autosomal dominant; the remaining 7 % were sporadic cases and/or had a multifactorially determined xanthomatosis. More sibs that offspring were affected; this was particularly pronounced for males with a IIA lipoprotein pattern. The genetic analysis gave no reason to suspect that hypercholesterolaemia with a IIA pattern is not the same disease as hypercholesterolaemia with a IIB pattern. However, a significant number of xanthomatosis patients had more than one type of hyperlipoproteinaemia. The frequency of the xanthomatosis trait was estimated to be 3.2/1000, and the ascertainment probability 0.6. The prevalence of familial hypercholesterolaemia with xanthomatosis was estimated to be 2.2/1000 and the multiple type hyperlipoproteinaemia with xanthomatosis had a frequency of 1.0/1000.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 174852     DOI: 10.1111/j.1399-0004.1976.tb01569.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  9 in total

1.  Family similarities in the age at coronary death in familial hypercholesterolaemia.

Authors:  A Heiberg; J Slack
Journal:  Br Med J       Date:  1977-08-20

Review 2.  Familial hypercholesterolemia: developments in diagnosis and treatment.

Authors:  Gerald Klose; Ulrich Laufs; Winfried März; Eberhard Windler
Journal:  Dtsch Arztebl Int       Date:  2014-08-04       Impact factor: 5.594

3.  Monogenic disorders.

Authors:  C O Carter
Journal:  J Med Genet       Date:  1977-10       Impact factor: 6.318

4.  Molecular genetic evidence for a founder effect in familial hypercholesterolemia among French Canadians.

Authors:  C Bétard; A M Kessling; M Roy; A Chamberland; S Lussier-Cacan; J Davignon
Journal:  Hum Genet       Date:  1992-03       Impact factor: 4.132

5.  Subjects with molecularly defined familial hypercholesterolemia or familial defective apoB-100 are not being adequately treated.

Authors:  Trond P Leren; Knut Erik Berge
Journal:  PLoS One       Date:  2011-02-18       Impact factor: 3.240

6.  Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society.

Authors:  Børge G Nordestgaard; M John Chapman; Steve E Humphries; Henry N Ginsberg; Luis Masana; Olivier S Descamps; Olov Wiklund; Robert A Hegele; Frederick J Raal; Joep C Defesche; Albert Wiegman; Raul D Santos; Gerald F Watts; Klaus G Parhofer; G Kees Hovingh; Petri T Kovanen; Catherine Boileau; Maurizio Averna; Jan Borén; Eric Bruckert; Alberico L Catapano; Jan Albert Kuivenhoven; Päivi Pajukanta; Kausik Ray; Anton F H Stalenhoef; Erik Stroes; Marja-Riitta Taskinen; Anne Tybjærg-Hansen
Journal:  Eur Heart J       Date:  2013-08-15       Impact factor: 29.983

7.  Mortality among patients with familial hypercholesterolemia: a registry-based study in Norway, 1992-2010.

Authors:  Liv Mundal; Mirza Sarancic; Leiv Ose; Per Ole Iversen; Jens-Kristian Borgan; Marit B Veierød; Trond P Leren; Kjetil Retterstøl
Journal:  J Am Heart Assoc       Date:  2014-12-02       Impact factor: 5.501

Review 8.  Estimating the prevalence of heterozygous familial hypercholesterolaemia: a systematic review and meta-analysis.

Authors:  Leo E Akioyamen; Jacques Genest; Shubham D Shan; Rachel L Reel; Jordan M Albaum; Anna Chu; Jack V Tu
Journal:  BMJ Open       Date:  2017-09-01       Impact factor: 2.692

9.  The Gulf Familial Hypercholesterolemia Registry (Gulf FH): Design, Rationale and Preliminary Results.

Authors:  Khalid Al-Rasadi; Khalid F Alhabib; Faisal Al-Allaf; Khalid Al-Waili; Ibrahim Al-Zakwani; Ahmad AlSarraf; Wael Almahmeed; Nasreen AlSayed; Mohammad Alghamdi; Mohammed A Batais; Turky H Almigbal; Fahad Alnouri; Abdulhalim Kinsara; Ashraf Hammouda; Zuhier Awan; Heba Kary; Omer A Elamin; Fahad Zadjali; Mohammed Al-Jarallah; Abdullah Shehab; Hani Sabbour; Haitham Amin; Hani Altaradi
Journal:  Curr Vasc Pharmacol       Date:  2020       Impact factor: 2.719

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.